Clinical Trials Browser

Phase 2 × Uveal Melanoma × gp100 Melanoma Antigen × Clear all

NCT00085189 2014-05-22

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma